Peter J. Arduini, President and CEO of GE HealthCare, Named Chair of AdvaMed Board of Directors

AdvaMed logo

December 11, 2023 | WASHINGTON, D.C.,  – Today, AdvaMed, the Medtech Association, announced that Peter J. Arduini, president and CEO of GE HealthCare, will become the Chair of the AdvaMed Board of Directors.

“The entire board and the global industry AdvaMed represents are very excited to have Peter as our new Board Chair during this critical time for medtech. Artificial Intelligence, imaging and digital technology represent important areas of innovation that can significantly accelerate diagnosis and improve the personalization of patient care. Peter’s proven record of leadership across more than three decades in medtech and imaging will enable him to advance AdvaMed’s goal of achieving healthier lives and healthier communities around the world. I look forward to working with him,” said AdvaMed President and CEO Scott Whitaker, who also serves as President of the AdvaMed Board of Directors.

Arduini said, “I appreciate the confidence my fellow AdvaMed Board members have placed in me as the Board’s new chair.  Through Scott’s leadership, AdvaMed has become a unifying voice for our industry to foster growth and innovative new solutions for patients, providers and health systems. The medical technology industry is at the forefront of defining the future of healthcare through smart devices, diagnostics and digital solutions that can enable earlier and more precise diagnoses, targeted treatments and improved patient outcomes. We need policies that keep pace with innovation, while fostering the highest ethical standards that improve patient access to the best care possible. With the promise of artificial intelligence and the interconnectivity of medical technologies, there has never been a more important time in our history to make profound and lasting changes in the delivery of care for patients.” 

Arduini has been president and chief executive officer of GE HealthCare, a global medical technology, pharmaceutical diagnostics, and digital solutions innovator, since January 2022.  He previously served as president and chief executive officer of Integra LifeSciences Holdings Corporation, corporate vice president and president of Medication Delivery, Baxter Healthcare, from 2005 to 2010. He previously spent 15 years at GE Healthcare where in a variety of management roles for domestic and global businesses, culminating in leading the global functional imaging business. Arduini also serves on the Boards of Directors of GE HealthCare, Bristol Myers Squibb and the National Italian American Foundation.

In the wake of former AdvaMed Chair Ashley McEvoy’s departure from Johnson & Johnson Medtech in October, Arduini stepped in to serve as interim chair over the past several weeks. The full Board elected him unanimously to a two-year term, which began immediately Friday.

Arduini  will unveil his priorities as AdvaMed Chair in early 2024.

Georgia Life Sciences Applauds Congressman McCormick for Introducing Federal Biotech Leadership Legislation

July 24, 2026
July 24, 2026, Atlanta, GA - Georgia Life Sciences applauds Congressman Rich McCormick (R-GA) for introducing the Biotechnology Diplomacy Leadership Act , legislation designed to strengthen America's leadership in biotechnology by establishing a senior biotechnology leadership position within the U.S. Department of State. As biotechnology continues to drive breakthroughs in healthcare, agriculture, advanced manufacturing, and national security, the United States must remain a global leader in innovation while strengthening strategic partnerships with allies around the world. The proposed legislation recognizes biotechnology as a critical component of U.S. economic competitiveness and foreign policy and would help ensure that the federal government is well positioned to advance these priorities internationally. The legislation also reflects recommendations from the National Security Commission on Emerging Biotechnology , which called for a more coordinated national approach to advancing biotechnology and protecting U.S. leadership in this strategically important sector. "Georgia is home to one of the nation's fastest-growing life sciences ecosystems, and policies that strengthen America's global biotechnology leadership directly benefit innovators, researchers, manufacturers, and patients," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "We appreciate Congressman McCormick's leadership in recognizing biotechnology as both an economic engine and a strategic national priority." Georgia Life Sciences looks forward to working with policymakers at both the federal and state levels to advance policies that foster innovation, strengthen the U.S. bioeconomy, and ensure America remains the global leader in biotechnology.

Georgia Life Sciences Names Renee' Martin, Ph.D., Program Manager to Lead Flagship Educator Workforce Development Program

July 21, 2026
Georgia Life Sciences names Renee Martin, Ph.D., to lead its Teacher Training Initiative, advancing educator workforce development and Georgia's future life sciences talent pipeline.

Georgia Life Sciences Partnership Expands Plant Biotechnology Education for Agriscience Teachers Across Georgia

July 17, 2026
FOR IMMEDIATE RELEASE  July 16, 2026 ATLANTA, Ga . – Eighteen Georgia high school agriscience teachers recently participated in a hands-on plant tissue culture training at Cedar Shoals High School in Athens, equipping educators with biotechnology skills and classroom resources that will expand access to experiential STEM learning for students across the state. Hosted through a partnership led by Georgia Life Sciences (GLS), the workshop was facilitated by Julie Throne, Agriscience Teacher, FFA Advisor, and CTAE Department Chair at Cedar Shoals High School. Participants received practical instruction in plant tissue culture techniques using newly developed portable tissue culture kits generously donated by California-based Athena Ag. Plant tissue culture is a foundational biotechnology technique used in agriculture and plant science research to propagate plants under aseptic conditions. By incorporating these concepts into agriscience classrooms, educators can provide students with hands-on experiences that introduce biotechnology while building technical skills relevant to careers in agriculture and biotechnology. As part of the workshop, each participating teacher received two complete plant tissue culture kits to take back to their school, enabling students throughout Georgia to engage in laboratory-based biotechnology activities and explore emerging career pathways in the life sciences. "Providing educators with access to industry-relevant training and classroom resources is one of the most effective ways to inspire the next generation of Georgia's life sciences workforce," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "Through partnerships like this, we're helping teachers bring real-world biotechnology into their classrooms while expanding opportunities for students to discover careers in one of Georgia's fastest-growing industries." The training is part of Georgia Life Sciences' broader Teacher Training Initiative, a statewide workforce development program that equips middle and high school educators with the knowledge, tools, and industry connections needed to deliver hands-on biotechnology instruction. Through strategic partnerships with industry, education, and nonprofit organizations, the initiative continues to strengthen Georgia's talent pipeline by connecting classroom learning with real-world workforce opportunities. Georgia Life Sciences extends its appreciation to Julie Throne for leading the training and to Athena for its generous donation of classroom kits, helping expand access to biotechnology education for educators and students across the state.
MORE POSTS